AM

Amol Manohar Mhatre

Active Director Director DIN 09840891
DIN 09840891 First appointment Jan 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Amol Manohar Mhatre

Data last updated:

Amol Manohar Mhatre is a Director at Rudrashri Lifesciences Private Limited (since 2023). The company operates in Pharma. Rudrashri Lifesciences Private Limited reported revenue of ₹114 Cr (FY 2024).

DIN 09840891
Primary Designation Director
Industry Pharma
First Appointment 02 Jan 2023
Oldest Company Age 4 yrs
Largest company Rudrashri Lifesciences Private Limited · ₹114 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jan 20232022₹114 Cr (FY 2024)Active

Board colleagues of Amol Manohar Mhatre

Directorship timeline

Open interactive timeline →
Rudrashri Lifesciences Private Limited
Premium access

Shareholding and investment profile for Amol Manohar Mhatre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Manohar Mhatre

Amol Manohar Mhatre currently holds 1 directorship: Rudrashri Lifesciences Private Limited (Director, since 02 Jan 2023, revenue ₹114 Cr (FY 2024)).

Amol Manohar Mhatre was first appointed on 02 Jan 2023 as Director at Rudrashri Lifesciences Private Limited.

The current boards of Amol Manohar Mhatre's companies include Narayan Santosh Goyal (Rudrashri Lifesciences Private Limited), Siddhant Goyal (Rudrashri Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available